Immunological Approach to the Identification and Development of Vaccines to Various Toxins (original) (raw)

International Journal of Toxicology, 2011

View PDFchevron_right

Anti-idiotype-based vaccines against biological toxins

Trần Chánh

Toxicology and Applied Pharmacology, 1991

View PDFchevron_right

Immunization against Potential Biological Warfare Agents

Julie Pavlin

Clinical Infectious Diseases, 2000

View PDFchevron_right

Immunogenic properties of trivalent recombinant protein composed of B-subunits of LT, STX-2, and CT toxins

A. Salmanian

Microbes and Infection, 2016

View PDFchevron_right

Anti-idiotype vaccines in toxicology

Trần Chánh

International Journal of Clinical and Laboratory Research, 1992

View PDFchevron_right

Validation of the combined toxin-binding

Trần Ngọc Nhon

View PDFchevron_right

Delivery of Antigens to the MHC Class I Pathway Using Bacterial Toxins

Kurt Klimpel

Human Immunology, 1997

View PDFchevron_right

Thermostable ricin vaccine protects rhesus macaques against aerosolized ricin: Epitope-specific neutralizing antibodies correlate with protection

Peter Didier, Chad Roy

Proceedings of the National Academy of Sciences, 2015

View PDFchevron_right

Induction of neutralizing antibodies against Tityus serrulatus toxins by immunization with a recombinant nontoxic protein

Carlos Chávez-Olórtegui

Toxicon, 2000

View PDFchevron_right

Antibodies for biodefense

Thibaut Pelat

Mabs, 2011

View PDFchevron_right

New Method To Generate Enzymatically Deficient Clostridium difficile Toxin B as an Antigen for Immunization

Harald Genth

Infection and Immunity, 2000

View PDFchevron_right

Biophysical characterization and immunization studies of dominant negative inhibitor (DNI), a candidate anthrax toxin subunit vaccine

Kiran Andra

2013

View PDFchevron_right

AN OVERVIEW: IMMUNOTOXIN

Editor iajps

View PDFchevron_right

Bivalent Recombinant Vaccine for Botulinum Neurotoxin Types A and B Based on a Polypeptide Comprising Their Effector and Translocation Domains That Is Protective against the Predominant A and B Subtypes

Xiaomi An

Infection and Immunity, 2009

View PDFchevron_right

Production of catalytically inactive BoNT/A1 holoprotein and comparison with BoNT/A1 subunit vaccines against toxin subtypes A1, A2, and A3

Robert Webb

Vaccine, 2009

View PDFchevron_right

Structure alteration and immunological properties of 60 Co-gamma-rays irradiated bothropstoxin-I

Andres Jimenez Galisteo Jr

… of radioanalytical and …, 2010

View PDFchevron_right

Polyclonal antibodies in livestock for treatment of ingested toxin in human

shreen nusair

2012

View PDFchevron_right

Efficacy of a Potential Trivalent Vaccine Based on Hc Fragments of Botulinum Toxins A, B, and E Produced in a Cell-Free Expression System

Shaul Reuveny

Clinical and Vaccine Immunology, 2010

View PDFchevron_right

Oral immunization with a lettuce-derived Escherichia coli heat-labile toxin B subunit induces neutralizing antibodies in mice

Leticia Moreno-fierros

Plant Cell, Tissue and Organ Culture (PCTOC), 2011

View PDFchevron_right

Vaccine Analysis: Strategies, Principles, and Control

Vincent Turula

2015

View PDFchevron_right

Immune response and neutralization capacity of antibodies produced in young sheep immunized with Crotalus durissus terrificus native or Cobalt-60 irradiated venom

Benedito Barraviera

2009

View PDFchevron_right

Trivalent Vaccine against Botulinum Toxin Serotypes A, B, and E That Can Be Administered by the Mucosal Route

Ajay Singh

Infection and Immunity, 2007

View PDFchevron_right

Towards a recombinant vaccine against diphtheria toxin

Pascal Drevet

Infection and Immunity

View PDFchevron_right

Immunization, Vaccines and Biologicals

Diab Dima

View PDFchevron_right

Addressing the Immunogenicity of the Cargo and of the Targeting Antibodies with a Focus on Deimmunized Bacterial Toxins and on Antibody-Targeted Human Effector Proteins

Itai Benhar

Biomedicines

View PDFchevron_right

Vaccine Antigens Responses to Nasally Administered as an Adjuvant for Mucosal Immune

Alexandra Duverger

View PDFchevron_right

Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: Use as a conjugation protein in vaccines and other potential clinical applications

Lisa DeTora

Biologicals, 2011

View PDFchevron_right

Expression and Purification of Anthrax Toxin Protective Antigen fromEscherichia coli

Arun Prasad Chopra

Protein Expression and Purification, 1996

View PDFchevron_right

Immunological Characteristics Associated with the Protective Efficacy of Antibodies to Ricin1

Royce Wilkinson

View PDFchevron_right

Ricin with the Protective Efficacy of Antibodies to Immunological Characteristics Associated Downloaded from

Massimo Maddaloni

View PDFchevron_right

Immunological Approach to the Identification and Development of Vaccines to Various Toxins (original) (raw)

Related papers